Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa

Jürg Dreier1, Paolo Ruggerone2

  • 1Basilea Pharmaceutica International Ltd., Basel, Switzerland.

Insights

Pseudomonas aeruginosa exhibits multidrug resistance due to efflux pumps like MexAB-OprM. Understanding how these pumps affect antibiotic activity is crucial for developing new treatments against challenging infections.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Pseudomonas aeruginosa infections are increasingly difficult to treat due to antibiotic resistance.
  • Multidrug resistance is often mediated by the hyperexpression of Resistance-Nodulation-Cell Division (RND)-type multidrug efflux pumps.
  • Specific efflux pumps, such as MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprA, are frequently detected in clinical isolates.

Purpose of the Study:

  • To review substrate recognition patterns of RND-type multidrug efflux pumps in Pseudomonas aeruginosa.
  • To elucidate the impact of efflux on antibiotic activity, considering variations between antibiotic classes and individual compounds.
  • To focus on the MexB subunit of the primary RND transporter in P. aeruginosa.

Main Methods:

  • Review of experimental evidence regarding efflux pump substrate recognition.
  • Analysis of computer simulations to understand compound-pump and compound-solvent interactions.
  • High-resolution techniques to gain insight into the functioning of these molecular machineries.

Main Results:

  • The impact of efflux pumps on antibiotic activity varies significantly, even among antibiotics within the same class.
  • Physicochemical properties of antibiotic-pump interactions are key determinants of efflux pump substrate specificity.
  • MexB, a subunit of the main RND transporter, plays a critical role in substrate recognition.

Conclusions:

  • Understanding efflux pump substrate recognition is vital for overcoming multidrug resistance in P. aeruginosa.
  • Targeting specific efflux pump mechanisms, like those involving MexB, could lead to more effective antimicrobial strategies.
  • Further research combining experimental and computational approaches is needed to fully understand these complex systems.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
115
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
895
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.6K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
56